FOR IMMEDIATE RELEASE THURSDAY, MAY 31, 2018
Contact: Tara Downes
COMPTROLLER LEMBO: GROUNDBREAKING PRESCRIPTION DRUG REFORM NOW LAW IN CT
Comptroller Kevin Lembo announced that An Act Concerning Prescription Drug Costs is now state law in Connecticut with Gov. Dannel P. Malloy’s signature today, establishing new groundbreaking transparency requirements for pharmaceutical corporations when drug prices skyrocket.
Lembo and State Rep. Sean Scanlon (D-Guilford), co-chair of the Insurance and Real Estate Committee, championed the legislation, obtaining unanimous support from both the state House and Senate.
“This is an extraordinary victory for Connecticut patients who pay outrageous prices at the counter while powerful corporations are enriched by big discounts,” Lembo said. “The extreme wealth exchange between corporate giants, from pharmaceutical manufacturers to pharmacy benefit managers to insurance companies, will no longer happen in the dark. This legislative victory is a groundbreaking step, but the fight for fairness has only just begun as we continue the fight for relief at the pharmacy counter.
“I am grateful to legislative leadership, Governor Malloy and particularly Rep. Scanlon, for their commitment to pharmaceutical market reform.”